Eli Lilly - Manufacturing Investment (February 2026): Eli Lilly reported $1.5 billion pre-launch inventory for orforglipron and announced new manufacturing facilities as part of $27 billion investment drive [4]
Rosenstock J, Fonseca VA, Gross JL, Ratner RE, Ahrn B, Chow FCC, et al
Your provider can help determine if and when resuming medication might be appropriate, or whether alternative interventions should be considered
However, this is harder to self-administer correctly, so we usually recommend sticking with the thigh or stomach
,
Step 4: Follow the standard tirzepatide titration: Weeks 14: 2.5mg Weeks 58: 5mg Weeks 912: 7.5mg (if needed) Continue increasing by 2.5mg every 4 weeks as tolerated, up to 15mg maximum Step 5: Find your effective dose